Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting 6 Reasons Why Early Oncology Drug Trials Fail (And How to Avoid Them) By Premier Research January 2, 2018 Consulting 5 Operational Considerations for Rare Disease Trials By Nach Davé December 27, 2017 Consulting Heart Valve Studies: 6 key players required for success By Premier Research December 20, 2017 Consulting Optimizing Regulatory Considerations for Orphan-Drug Development on a Global Scale By Nach Davé December 19, 2017 Medical and Regulatory Affairs Stronger Post-Market Studies Needed if FDA Speeds New Medical Device Approval By Nach Davé December 14, 2017 Consulting The 3 Ds of a Successful Strategic Sponsor-CRO Partnership By Krista Armstrong December 13, 2017 Previous 1 …35 36 37 38 39 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today